Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 10Cholangiocarcinoma 8Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Neoplasms 2Gallbladder Neoplasms 2Pancreatic Cancer Metastatic to Liver 1Klatskin Tumor 1Gastrointestinal Neoplasms 1Fistula 1Disease 1Choledocholithiasis 1Cholangitis, Sclerosing 1Biliary Tract Diseases 1Biliary Fistula 1Bile Duct Diseases 1

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Gastrointestinal × Clear all
NCT03504293 2020-12-22

The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions

Sahlgrenska University Hospital

Completed
90 enrolled
Gastrointestinal

Biliary Tract Diseases, Biliary Tract Neoplasms, Neoplasms

NCT00907413 2015-06-03

PDT

Weill Medical College of Cornell University

Phase 3 Terminated
50 enrolled
Gastrointestinal

Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡